Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Post by julia7777777777on Nov 12, 2019 4:35pm
110 Views
Post# 30342063

this kind of sums it all up

this kind of sums it all upThe Financial Post reports in its Tuesday edition that investors searching for a bandage to stanch the bleeding in pot stocks are not going to find it in third-quarter earnings. A Bloomberg dispatch to the Post says that four of the largest Canadian pot companies by market value will report results for the quarter ended Sept. 30 this week and the expectations are low. This does not bode well for stock prices, which are already down nearly 60 per cent for the sector from recent highs in March. Investors are likely to focus on "timetables toward EBITDA profitability," which probably is not in the cards until 2020 or 2021, according to Bloomberg Intelligence analyst Kenneth Shea. (EBITDA is short for earnings before interest, taxes, depreciation and amortization.) Bank of Montreal analyst Tamy Chen expects industry-wide sales to Canada's provincial wholesalers to decline 20 per cent quarter-over-quarter amid a slow rollout of retail storefronts that has left them sitting on too much inventory.


And mmen with all its stores in Cali And Florida trading at year lows...........


The sector has been a disaster....................(over the last 6-12 months)

but if cool can show any kind of decent revenue going forward................(with its low float)..............acb has over a billion shares outstanding

You just never know ..................

GLTA
Bullboard Posts